Company intelligence / Profile preview

Regenerative Pain & Spine

Chicago, Illinois, United Statesrpspine.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Regenerative Pain & Spine provides interventional and regenerative therapies for adults with acute or chronic musculoskeletal and neuropathic pain. The clinic customizes treatment plans using the latest evidence-based approaches to deliver long-lasting relief. No investigational drugs/devices; all services are standard-of-care clinical offerings.

Therapeutic areas: RheumatologyNeurology
Modalities: Interventional procedures (e.g., spinal cord stimulation)Medications (pain management)Physical therapy referrals and monitoring servicesEvidence-based treatments for pain relief
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

rebonuputemcel

Phase 3

Indications: Lumbar degenerative disc disease

Beyond the preview

Go deeper on Regenerative Pain & Spine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenerative Pain & Spine.

Explore the full profile